This biomarker regulates the activation of the AKT signal pathway and interacts with the beta-catenin which could be one of the mechanisms, by which it maintains the characteristics of esophageal squamous cell carcinoma (ESCC) and cancer stem-like cells (CSCs) [63]. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.